Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FXOther monoclonal antibodies and antibody drug conjugates
- Chemical substanceL01FX12Tafasitamab
Where it is registered
Each register with its number of medicines and a few of them.
Brazil
Anvisa · 1 medicine
Canada
Health Canada · 1 medicine
Spain
AEMPS · 1 medicine
European Union



